Anti-malaria drug touted by Trump has high death risk in COVID-19 patients, new study shows

Hospitalized COVID-19 patients who were treated with hydroxychloroquine, an anti-malaria touted by President Trump, had a much higher risk of death than those who were not, according to a new study of 96,000 patients.The study, published Friday in the medical journal The Lancet, found that patients who were treated with hydroxychloroquine or chloroquine also faced a much higher risk of abnormal heartbeats, called arrhythmias, which could…